Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| cis-trans-Isomerases | 19 | 2022 | 32 | 3.300 |
Why?
|
| Eye Proteins | 17 | 2022 | 33 | 2.320 |
Why?
|
| Retinal Pigment Epithelium | 10 | 2021 | 18 | 1.610 |
Why?
|
| Retina | 12 | 2022 | 50 | 1.430 |
Why?
|
| Carrier Proteins | 13 | 2011 | 131 | 1.280 |
Why?
|
| PPAR alpha | 8 | 2023 | 29 | 1.240 |
Why?
|
| Animals | 43 | 2023 | 7302 | 0.940 |
Why?
|
| MicroRNAs | 5 | 2018 | 173 | 0.920 |
Why?
|
| Diabetic Retinopathy | 7 | 2018 | 64 | 0.900 |
Why?
|
| Mice | 26 | 2023 | 2372 | 0.840 |
Why?
|
| Pigment Epithelium of Eye | 6 | 2012 | 10 | 0.780 |
Why?
|
| Retinal Degeneration | 5 | 2018 | 14 | 0.740 |
Why?
|
| Ischemia | 3 | 2022 | 92 | 0.660 |
Why?
|
| Receptors, LDL | 4 | 2021 | 64 | 0.660 |
Why?
|
| Mutagenesis, Site-Directed | 9 | 2014 | 60 | 0.640 |
Why?
|
| Hydrolases | 3 | 2008 | 6 | 0.630 |
Why?
|
| Zebrafish | 3 | 2012 | 24 | 0.630 |
Why?
|
| Vision, Ocular | 4 | 2022 | 30 | 0.570 |
Why?
|
| Retinal Pigments | 3 | 2005 | 8 | 0.570 |
Why?
|
| Retinal Cone Photoreceptor Cells | 4 | 2011 | 5 | 0.570 |
Why?
|
| Neovascularization, Pathologic | 2 | 2022 | 81 | 0.550 |
Why?
|
| Mice, Knockout | 14 | 2023 | 425 | 0.540 |
Why?
|
| Amino Acid Sequence | 10 | 2012 | 280 | 0.520 |
Why?
|
| Molecular Sequence Data | 10 | 2012 | 350 | 0.520 |
Why?
|
| Macular Degeneration | 3 | 2021 | 21 | 0.500 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 89 | 0.500 |
Why?
|
| Mutation, Missense | 1 | 2014 | 48 | 0.490 |
Why?
|
| Cell Membrane | 3 | 2009 | 98 | 0.490 |
Why?
|
| Blotting, Western | 11 | 2017 | 281 | 0.460 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2009 | 3 | 0.440 |
Why?
|
| Catalytic Domain | 1 | 2012 | 58 | 0.430 |
Why?
|
| Point Mutation | 3 | 2006 | 23 | 0.420 |
Why?
|
| Disease Models, Animal | 10 | 2022 | 981 | 0.420 |
Why?
|
| Vitamin A | 7 | 2018 | 19 | 0.410 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2011 | 73 | 0.390 |
Why?
|
| Isotretinoin | 1 | 2011 | 12 | 0.390 |
Why?
|
| Cells, Cultured | 11 | 2021 | 800 | 0.390 |
Why?
|
| Fibrosis | 3 | 2021 | 103 | 0.390 |
Why?
|
| Cell Line | 6 | 2021 | 450 | 0.380 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2023 | 52 | 0.380 |
Why?
|
| Retinoids | 4 | 2021 | 41 | 0.370 |
Why?
|
| Palmitates | 2 | 2006 | 4 | 0.370 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 95 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2020 | 180 | 0.360 |
Why?
|
| Frizzled Receptors | 3 | 2021 | 5 | 0.360 |
Why?
|
| Glutamic Acid | 2 | 2009 | 46 | 0.350 |
Why?
|
| Retinal Diseases | 2 | 2022 | 18 | 0.340 |
Why?
|
| Palmitic Acid | 1 | 2008 | 11 | 0.340 |
Why?
|
| Chickens | 4 | 2014 | 40 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2020 | 1383 | 0.330 |
Why?
|
| Humans | 26 | 2023 | 29220 | 0.300 |
Why?
|
| Rod Opsins | 4 | 2006 | 4 | 0.290 |
Why?
|
| Diabetic Nephropathies | 3 | 2020 | 195 | 0.280 |
Why?
|
| Histidine | 1 | 2005 | 5 | 0.270 |
Why?
|
| Retinal Rod Photoreceptor Cells | 4 | 2011 | 5 | 0.240 |
Why?
|
| Brain | 1 | 2011 | 930 | 0.240 |
Why?
|
| Culture Media, Conditioned | 2 | 2021 | 52 | 0.230 |
Why?
|
| Kinetics | 4 | 2011 | 205 | 0.230 |
Why?
|
| Genes, Dominant | 1 | 2022 | 26 | 0.210 |
Why?
|
| beta Catenin | 4 | 2016 | 37 | 0.210 |
Why?
|
| Amino Acid Substitution | 3 | 2014 | 40 | 0.210 |
Why?
|
| Down-Regulation | 4 | 2017 | 143 | 0.210 |
Why?
|
| Cattle | 5 | 2014 | 100 | 0.210 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 3 | 0.210 |
Why?
|
| Photoreceptor Cells | 1 | 2001 | 1 | 0.210 |
Why?
|
| Mitochondria | 2 | 2023 | 174 | 0.200 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 11 | 0.200 |
Why?
|
| Ligands | 1 | 2021 | 81 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 711 | 0.190 |
Why?
|
| Smad2 Protein | 1 | 2020 | 7 | 0.190 |
Why?
|
| Smad3 Protein | 1 | 2020 | 11 | 0.190 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 27 | 0.190 |
Why?
|
| Kidney Tubules | 1 | 2020 | 25 | 0.190 |
Why?
|
| Rats | 6 | 2017 | 1604 | 0.180 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2018 | 1 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2011 | 93 | 0.170 |
Why?
|
| Signal Transduction | 2 | 2020 | 667 | 0.170 |
Why?
|
| RNA, Messenger | 5 | 2013 | 514 | 0.160 |
Why?
|
| Retinal Neurons | 1 | 2017 | 2 | 0.160 |
Why?
|
| Subcellular Fractions | 2 | 2008 | 14 | 0.160 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 519 | 0.160 |
Why?
|
| Rhodopsin | 1 | 2017 | 4 | 0.160 |
Why?
|
| Acyltransferases | 4 | 2011 | 16 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 249 | 0.150 |
Why?
|
| Species Specificity | 3 | 2014 | 84 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 162 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2017 | 93 | 0.150 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 100 | 0.150 |
Why?
|
| Capillary Permeability | 2 | 2013 | 15 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 271 | 0.150 |
Why?
|
| Protein Isoforms | 1 | 2016 | 56 | 0.140 |
Why?
|
| COS Cells | 4 | 2009 | 28 | 0.140 |
Why?
|
| Diabetes, Gestational | 1 | 2016 | 21 | 0.140 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2005 | 18 | 0.140 |
Why?
|
| Tyrosine | 2 | 2013 | 22 | 0.140 |
Why?
|
| Mutation | 3 | 2022 | 466 | 0.130 |
Why?
|
| Recombinant Proteins | 5 | 2012 | 248 | 0.130 |
Why?
|
| Retinaldehyde | 4 | 2017 | 8 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2014 | 11 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 82 | 0.120 |
Why?
|
| Salamandridae | 3 | 2003 | 3 | 0.120 |
Why?
|
| Pericytes | 1 | 2014 | 28 | 0.120 |
Why?
|
| Retinal Vessels | 1 | 2014 | 18 | 0.120 |
Why?
|
| Models, Molecular | 2 | 2005 | 178 | 0.120 |
Why?
|
| Kidney | 3 | 2016 | 486 | 0.120 |
Why?
|
| Cloning, Molecular | 2 | 2011 | 74 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2016 | 239 | 0.120 |
Why?
|
| Antioxidants | 1 | 2014 | 114 | 0.120 |
Why?
|
| Receptors, Neuropeptide | 1 | 2013 | 3 | 0.110 |
Why?
|
| Apoptosis | 4 | 2017 | 337 | 0.110 |
Why?
|
| Phenylalanine | 1 | 2012 | 5 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 34 | 0.110 |
Why?
|
| Genetic Vectors | 3 | 2009 | 118 | 0.110 |
Why?
|
| Leucine | 1 | 2012 | 24 | 0.110 |
Why?
|
| Visual Pathways | 2 | 2017 | 29 | 0.110 |
Why?
|
| Substrate Specificity | 1 | 2012 | 84 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2017 | 248 | 0.100 |
Why?
|
| Vitamin A Deficiency | 1 | 2011 | 2 | 0.100 |
Why?
|
| Oxidative Stress | 4 | 2014 | 223 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 145 | 0.100 |
Why?
|
| Pyridinium Compounds | 1 | 2010 | 4 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 196 | 0.100 |
Why?
|
| Evolution, Molecular | 3 | 2005 | 36 | 0.090 |
Why?
|
| Iron | 1 | 2011 | 113 | 0.090 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2009 | 1 | 0.090 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 159 | 0.090 |
Why?
|
| Lipid Bilayers | 1 | 2009 | 6 | 0.090 |
Why?
|
| Phospholipids | 1 | 2009 | 27 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 57 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2005 | 33 | 0.080 |
Why?
|
| Phylogeny | 3 | 2005 | 58 | 0.080 |
Why?
|
| Transfection | 3 | 2014 | 192 | 0.080 |
Why?
|
| Alanine | 1 | 2006 | 27 | 0.070 |
Why?
|
| Gene Expression | 4 | 2011 | 332 | 0.070 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2006 | 1 | 0.070 |
Why?
|
| Inflammation | 2 | 2022 | 508 | 0.070 |
Why?
|
| Half-Life | 1 | 2006 | 22 | 0.070 |
Why?
|
| Cytosol | 1 | 2006 | 25 | 0.070 |
Why?
|
| Vertebrates | 1 | 2005 | 2 | 0.070 |
Why?
|
| Ferrous Compounds | 1 | 2005 | 6 | 0.070 |
Why?
|
| Xenopus laevis | 1 | 2005 | 5 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 46 | 0.070 |
Why?
|
| Cysteine | 1 | 2006 | 131 | 0.070 |
Why?
|
| Catalysis | 1 | 2005 | 64 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 83 | 0.070 |
Why?
|
| Mice, Mutant Strains | 2 | 2018 | 51 | 0.070 |
Why?
|
| Base Sequence | 2 | 2003 | 240 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 97 | 0.060 |
Why?
|
| In Situ Hybridization | 2 | 2002 | 35 | 0.060 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2017 | 5 | 0.060 |
Why?
|
| Diterpenes | 2 | 2018 | 15 | 0.060 |
Why?
|
| Wnt Proteins | 2 | 2016 | 18 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2016 | 39 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2003 | 21 | 0.060 |
Why?
|
| Protein Binding | 2 | 2016 | 199 | 0.060 |
Why?
|
| Binding Sites | 1 | 2003 | 125 | 0.060 |
Why?
|
| Cornea | 1 | 2023 | 15 | 0.060 |
Why?
|
| Nucleotidyltransferases | 1 | 2022 | 7 | 0.060 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 28 | 0.060 |
Why?
|
| Rats, Inbred BN | 2 | 2012 | 32 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2002 | 40 | 0.050 |
Why?
|
| Smad Proteins | 1 | 2021 | 7 | 0.050 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2021 | 7 | 0.050 |
Why?
|
| DNA | 1 | 2003 | 204 | 0.050 |
Why?
|
| Wound Healing | 1 | 2023 | 182 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 66 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2022 | 256 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2016 | 55 | 0.050 |
Why?
|
| Chromatography, Affinity | 2 | 2009 | 15 | 0.040 |
Why?
|
| Rana catesbeiana | 1 | 1999 | 1 | 0.040 |
Why?
|
| Amphibian Proteins | 1 | 1999 | 1 | 0.040 |
Why?
|
| Cyclin A1 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2018 | 15 | 0.040 |
Why?
|
| Blindness | 2 | 2009 | 9 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2009 | 12 | 0.040 |
Why?
|
| Female | 4 | 2018 | 18241 | 0.040 |
Why?
|
| Cell Movement | 1 | 2018 | 161 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 160 | 0.040 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2017 | 4 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2017 | 84 | 0.040 |
Why?
|
| Retinal Neovascularization | 1 | 2017 | 2 | 0.040 |
Why?
|
| Microsomes | 2 | 2008 | 14 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 250 | 0.040 |
Why?
|
| Glycosylation | 1 | 2016 | 15 | 0.040 |
Why?
|
| Trophoblasts | 1 | 2016 | 8 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2018 | 573 | 0.040 |
Why?
|
| Placenta | 1 | 2016 | 63 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2009 | 85 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 747 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 320 | 0.030 |
Why?
|
| Adult | 2 | 2018 | 8468 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2014 | 21 | 0.030 |
Why?
|
| Capillaries | 1 | 2014 | 23 | 0.030 |
Why?
|
| Male | 3 | 2018 | 17876 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2014 | 9 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 37 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 22 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2014 | 75 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 109 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2014 | 225 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 111 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 152 | 0.030 |
Why?
|
| Trypsin | 1 | 2013 | 12 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 118 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 816 | 0.030 |
Why?
|
| Oxygen | 1 | 2014 | 139 | 0.030 |
Why?
|
| Leukostasis | 1 | 2012 | 1 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2012 | 37 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 155 | 0.030 |
Why?
|
| Glucose | 1 | 2013 | 164 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 1366 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2012 | 82 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 14 | 0.030 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2011 | 1 | 0.030 |
Why?
|
| Opsins | 1 | 2011 | 2 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2011 | 41 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 481 | 0.030 |
Why?
|
| Cell Count | 1 | 2011 | 50 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 92 | 0.030 |
Why?
|
| Tretinoin | 1 | 2011 | 34 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2011 | 183 | 0.020 |
Why?
|
| Fluorescence | 1 | 2010 | 21 | 0.020 |
Why?
|
| Static Electricity | 1 | 2009 | 11 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 2413 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 629 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 50 | 0.020 |
Why?
|
| Liposomes | 1 | 2009 | 26 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 864 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 21 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 63 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 126 | 0.020 |
Why?
|
| Protein Transport | 1 | 2006 | 74 | 0.020 |
Why?
|
| Transducin | 1 | 2006 | 1 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 2006 | 3 | 0.020 |
Why?
|
| Schiff Bases | 1 | 2005 | 1 | 0.020 |
Why?
|
| Isomerism | 1 | 2005 | 6 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2005 | 45 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2005 | 17 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2006 | 61 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 9515 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 10872 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 373 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 68 | 0.010 |
Why?
|